Imagine that this shows that that Zilusol has a DMOAD affect. I personally think that this study is crucial to opening up so many other indications for it to be used as a complimentary treatment to help control inflammation in other diseases. For example that Australian Stem Cell company that just released information on Chronic Lower Back Pain and they used hyualoronic acid with the stem cells. What if they injected the stem cells with Zilusol. If this study shows which proteins it can help regulate, I would hope that this could open many opportunities for Zilusol to be used as a complimentary treatment.
Trial PAR008 is on ANZCTR, page-6
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $104.9M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 29.5¢ | $64.57K | 212.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 132329 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 227 | 2 |
View Market Depth
| Last trade - 13.56pm 16/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |